药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Yohimbine
Venetoclax
Venetoclax may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Yohimbine
Alectinib
Alectinib may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Yohimbine
Paritaprevir
Paritaprevir may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Yohimbine
Rolapitant
Rolapitant may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Yohimbine
Apalutamide
The excretion of Fimasartan can be increased when combined with Apalutamide.
Yohimbine
Lacidipine
Fimasartan may increase the hypotensive activities of Lacidipine.
Yohimbine
Quinoline Yellow WS
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinoline Yellow WS is combined with Fimasartan.
Yohimbine
Quinaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinaprilat is combined with Fimasartan.
Yohimbine
Perindoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindoprilat is combined with Fimasartan.
Yohimbine
Moexiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Moexiprilat is combined with Fimasartan.
Yohimbine
Trandolaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Trandolaprilat is combined with Fimasartan.
Yohimbine
Ramiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ramiprilat is combined with Fimasartan.
Yohimbine
Fosinoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinoprilat is combined with Fimasartan.
Yohimbine
Benazeprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Benazeprilat is combined with Fimasartan.
Yohimbine
Delapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Delapril is combined with Fimasartan.
Yohimbine
Zofenopril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Fimasartan.
Yohimbine
VTP-27999
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when VTP-27999 is combined with Fimasartan.
Yohimbine
Imidapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Imidapril is combined with Fimasartan.
Yohimbine
Enalaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalaprilat is combined with Fimasartan.
Yohimbine
Candesartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fimasartan is combined with Candesartan.